A 68-year-old woman with albuminuric CKD and T2D is on ACEi and SGLT2 inhibitor. Persistent albuminuria and high CV risk remain. Next agent to reduce ...

Question

A 68-year-old woman with albuminuric CKD and T2D is on ACEi and SGLT2 inhibitor. Persistent albuminuria and high CV risk remain. Next agent to reduce CV risk?

Accepted Answer

Nonsteroidal mineralocorticoid receptor antagonist (finerenone)

Answer

DPP-4 inhibitor

Answer

TZD

Answer

Basal insulin

Answer

No additional therapy

us-abim MCQ (SBA): Diabetic CKD-Finerenone

A 68-year-old woman with albuminuric CKD and T2D is on ACEi and SGLT2 inhibitor. Persistent albuminuria and high CV risk remain. Next agent to reduce CV risk?